Stock Track | China Shineway Pharmaceutical Soars 5.39% on Strong H1 Results and Dividend Announcement

Stock Track2025-08-27

China Shineway Pharmaceutical Group (02877.HK) saw its stock price surge 5.39% in intraday trading on Wednesday, following the release of impressive first-half financial results and the declaration of an interim dividend.

The pharmaceutical company reported robust financial performance for the first half of 2025. Sales reached RMB 1,652.7 million, while net income stood at RMB 614.7 million. Notably, the company maintained a high gross margin of 72.2%, indicating strong profitability in its core operations.

Adding to investor enthusiasm, China Shineway Pharmaceutical also declared a second interim dividend of RMB 11 cents per share for 2025. This dividend announcement, coupled with the strong financial results, likely contributed to the significant uptick in the company's stock price during the trading session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1167140309?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-08-27 13:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167140309","market":"us","top_or_hot":-1,"title":"Stock Track | China Shineway Pharmaceutical Soars 5.39% on Strong H1 Results and Dividend Announcement","media":"Stock Track","content":"<p>China Shineway Pharmaceutical Group (02877.HK) saw its stock price surge 5.39% in intraday trading on Wednesday, following the release of impressive first-half financial results and the declaration of an interim dividend.</p>\n\n<p>The pharmaceutical company reported robust financial performance for the first half of 2025. Sales reached RMB 1,652.7 million, while net income stood at RMB 614.7 million. Notably, the company maintained a high gross margin of 72.2%, indicating strong profitability in its core operations.</p>\n\n<p>Adding to investor enthusiasm, China Shineway Pharmaceutical also declared a second interim dividend of RMB 11 cents per share for 2025. This dividend announcement, coupled with the strong financial results, likely contributed to the significant uptick in the company's stock price during the trading session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | China Shineway Pharmaceutical Soars 5.39% on Strong H1 Results and Dividend Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | China Shineway Pharmaceutical Soars 5.39% on Strong H1 Results and Dividend Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-08-27 13:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>China Shineway Pharmaceutical Group (02877.HK) saw its stock price surge 5.39% in intraday trading on Wednesday, following the release of impressive first-half financial results and the declaration of an interim dividend.</p>\n\n<p>The pharmaceutical company reported robust financial performance for the first half of 2025. Sales reached RMB 1,652.7 million, while net income stood at RMB 614.7 million. Notably, the company maintained a high gross margin of 72.2%, indicating strong profitability in its core operations.</p>\n\n<p>Adding to investor enthusiasm, China Shineway Pharmaceutical also declared a second interim dividend of RMB 11 cents per share for 2025. This dividend announcement, coupled with the strong financial results, likely contributed to the significant uptick in the company's stock price during the trading session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02877","symbol_name":"神威药业","start_time":0,"source_url":"","article_id":"1167140309","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167140309","pubTimestamp":1756271861,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"China Shineway Pharmaceutical Group (02877.HK) saw its stock price surge 5.39% in intraday trading on Wednesday, following the release of impressive first-half financial results and the declaration...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02877":"神威药业"},"translate_title":"股票赛道|中国神威药业大涨5.39%H1业绩强劲及派息公告","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02877":1},"content_text":"China Shineway Pharmaceutical Group (02877.HK) saw its stock price surge 5.39% in intraday trading on Wednesday, following the release of impressive first-half financial results and the declaration of an interim dividend.\nThe pharmaceutical company reported robust financial performance for the first half of 2025. Sales reached RMB 1,652.7 million, while net income stood at RMB 614.7 million. Notably, the company maintained a high gross margin of 72.2%, indicating strong profitability in its core operations.\nAdding to investor enthusiasm, China Shineway Pharmaceutical also declared a second interim dividend of RMB 11 cents per share for 2025. This dividend announcement, coupled with the strong financial results, likely contributed to the significant uptick in the company's stock price during the trading session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1167140309","isCrawlerRequest":true}